Sumitomo Pharma Co (STU:DPM) Days Sales Outstanding : 66.93 (As of Sep. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Sumitomo Pharma Co Days Sales Outstanding?

Sumitomo Pharma Co's average Accounts Receivable for the three months ended in Sep. 2024 was €416 Mil. Sumitomo Pharma Co's Revenue for the three months ended in Sep. 2024 was €568 Mil. Hence, Sumitomo Pharma Co's Days Sales Outstanding for the three months ended in Sep. 2024 was 66.93.

The historical rank and industry rank for Sumitomo Pharma Co's Days Sales Outstanding or its related term are showing as below:

STU:DPM' s Days Sales Outstanding Range Over the Past 10 Years
Min: 81.24 Med: 95.69 Max: 105.53
Current: 89.33

During the past 13 years, Sumitomo Pharma Co's highest Days Sales Outstanding was 105.53. The lowest was 81.24. And the median was 95.69.

STU:DPM's Days Sales Outstanding is ranked worse than
67.32% of 970 companies
in the Drug Manufacturers industry
Industry Median: 71.605 vs STU:DPM: 89.33

Sumitomo Pharma Co's Days Sales Outstanding declined from Sep. 2023 (114.17) to Sep. 2024 (66.93).

Sumitomo Pharma Co Days Sales Outstanding Historical Data

The historical data trend for Sumitomo Pharma Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sumitomo Pharma Co Days Sales Outstanding Chart

Sumitomo Pharma Co Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Days Sales Outstanding

Get a 7-Day Free Trial

93.38

99.80

94.02

86.01

110.33

Sumitomo Pharma Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Days Sales Outstanding	Get a 7-Day Free Trial															114.17	104.06	102.69	85.08	66.93

Competitive Comparison of Sumitomo Pharma Co's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Sumitomo Pharma Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sumitomo Pharma Co's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sumitomo Pharma Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Sumitomo Pharma Co's Days Sales Outstanding falls into.

Sumitomo Pharma Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Sumitomo Pharma Co's Days Sales Outstanding for the fiscal year that ended in Mar. 2024 is calculated as

	Days Sales Outstanding (A: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Mar. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (670.172	+	497.543)	/	2 )	/	1931.625	*	365
=	583.8575					/	1931.625	*	365
=	110.33

Sumitomo Pharma Co's Days Sales Outstanding for the quarter that ended in Sep. 2024 is calculated as:

	Days Sales Outstanding (Q: Sep. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2024 )	+	Accounts Receivable (A: Sep. 2024 ))	/	count )	/	Revenue (A: Sep. 2024 )	*	Days in Period
=	( (0	+	416.377)	/	1 )	/	567.712	*	365 / 4
=	416.377					/	567.712	*	365 / 4
=	66.93

Sumitomo Pharma Co (STU:DPM) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Sumitomo Pharma Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Sumitomo Pharma Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Sumitomo Pharma Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sumitomo Pharma Co Ltd (STU:DPM) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

SMDPY:USA DNPUF:USA 4506:Japan

Address

6-8, Doshomachi 2-chome, Chuo-ku, Osaka, JPN, 541-0045

Website

https://www.sumitomo-pharma.com

Sumitomo Pharma Co Ltd is a specialty and generic drug manufacturing company. Sumitomo's vast majority of sales are generated in North America, followed by Japan. The company's core business is its pharmaceutical products business. The pharmaceutical business maintains a focus on a variety of areas, including cardiovascular/diabetes, psychiatry & neurology, and specialty areas. Sumitomo considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.